Since aromatase produced in pulmonary macrophages propagates estrogen-mediated airway inflammation [22], it is possible that a reduction in pulmonary estrogen levels from ADT may result in protective effects against second primary lung cancer. The gene discussed is CYP19A1; the disease is lung carcinoma.